141 related articles for article (PubMed ID: 8675585)
1. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines.
Ohta K; Pang XP; Berg L; Hershman JM
J Clin Endocrinol Metab; 1996 Jul; 81(7):2607-12. PubMed ID: 8675585
[TBL] [Abstract][Full Text] [Related]
2. Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell lines.
Yip I; Pang XP; Berg L; Hershman JM
J Clin Endocrinol Metab; 1995 May; 80(5):1664-9. PubMed ID: 7745015
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha-induced antiproliferation is not dependent on the autocrine action of TGF-beta 1 in a thyroid cancer cell line.
Pang XP; Yoshimura M; Wang J; Dubinett SM
Lymphokine Cytokine Res; 1994 Apr; 13(2):93-7. PubMed ID: 8061120
[TBL] [Abstract][Full Text] [Related]
4. Influence of cytokines on growth and differentiated function of FRTL5 cells.
Zakarija M; McKenzie JM
Endocrinology; 1989 Sep; 125(3):1260-5. PubMed ID: 2474435
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
6. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
[TBL] [Abstract][Full Text] [Related]
7. Alterations in TNF-alpha signal transduction in resistant human papillary thyroid carcinoma cells.
Pang XP; Ross NS; Hershman JM
Thyroid; 1996 Aug; 6(4):313-7. PubMed ID: 8875753
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 inhibits human thyroid carcinoma cell growth.
Kimura H; Yamashita S; Namba H; Tominaga T; Tsuruta M; Yokoyama N; Izumi M; Nagataki S
J Clin Endocrinol Metab; 1992 Aug; 75(2):596-602. PubMed ID: 1322431
[TBL] [Abstract][Full Text] [Related]
9. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
[TBL] [Abstract][Full Text] [Related]
10. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth.
Usa T; Tsukazaki T; Namba H; Ohtsuru A; Kimura H; Villadolid MC; Nagataki S; Yamashita S
Endocrinology; 1994 Oct; 135(4):1378-84. PubMed ID: 7925100
[TBL] [Abstract][Full Text] [Related]
11. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
12. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action.
Delomenie C; Wautier-Pepin MP; Chappey O; Wautier JL
Exp Cell Res; 1993 Jul; 207(1):122-30. PubMed ID: 7686496
[TBL] [Abstract][Full Text] [Related]
13. Combinatory responses of proinflamamtory cytokines on nitric oxide-mediated function in mouse calvarial osteoblasts.
Park YG; Kim KW; Song KH; Lee JM; Hong JJ; Moon SK; Kim CH
Cell Biol Int; 2009 Jan; 33(1):92-9. PubMed ID: 18957328
[TBL] [Abstract][Full Text] [Related]
14. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of four different cytokines on renal carcinoma cell lines.
Buszello H
Anticancer Res; 1995; 15(3):735-8. PubMed ID: 7645950
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.
Asano-Kato N; Fukagawa K; Okada N; Kawakita T; Takano Y; Dogru M; Tsubota K; Fujishima H
Exp Eye Res; 2005 Apr; 80(4):555-60. PubMed ID: 15781283
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells.
Pang XP; Park M; Hershman JM
Endocrinology; 1992 Jul; 131(1):45-50. PubMed ID: 1612026
[TBL] [Abstract][Full Text] [Related]
19. Effects of associated cytokines (IL-1, TNF-alpha, IFN-gamma and TGF-beta) on collagen and glycosaminoglycan production by cultured human synovial cells.
Daireaux M; Redini F; Loyau G; Pujol JP
Int J Tissue React; 1990; 12(1):21-31. PubMed ID: 2117000
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
